Biopreservation Market Report Global Forecast By Product (Equipment, Media, Laboratory Information Management System (LIMS)), Application (Regenerative Medicine, Biobanking, Drug Discovery), Countries and Company Analysis (2025-2033)

Biopreservation Market Size

Global Biopreservation Market is expected to touch US$ 5.44 billion in 2024 and to reach US$ 24.51 billion by 2033, with a CAGR of 18.20% during 2025-2033. The main driving factors behind this growth include the rising demand for personalized medicine, R&D investments, and growing awareness about rare diseases.

Biopreservation Industry Outlooks

Biopreservation is a method of using or handling the natural or controlled environment of microbiota with other biologically active agents in such a way that bio-material like cells, tissues, and organs do not deteriorate. Biopreservation is an extremely important process because it keeps biologically based samples viable, functional, and safe for long periods of time. In the health and life sciences sector, there are various applications of biopreservation practices, including the preservation and transport of human cells, tissues, vaccines, and much more.

In the medical application, biopreservation provides for preservation of viable and functional stem cells, blood products, and organs for transplantation when needed. In addition, it serves as a crucial additional support in the pharmaceutical industry in the development of biologics and personalized medicine. It prevents cell damage through freezing or chemical degradation, allowing such valuable biological materials to be preserved over long periods for clinical and research use.

Driving Forces of the Biopreservation Market

Increasing Demand for Personalized Medicine

The growing trend of treatment tailored to a patient's unique genetic makeup is undoubtedly one of the significant driving forces of the biopreservation market. Thus, demand exists for the preservation of samples such as stem cells and DNA and also tissue samples for their application in diagnostic and therapeutic areas. Biopreservation ensures such samples are preserved in viable form for research and clinical use. This translates to more effective, individualized treatments. As patients turn to personalized therapies in greater numbers, there would be greater demand for biopreservation technologies that are adequate, reliable, and strong enough in preserving the integrity of such samples.

Biotechnology Advancements and Research

There has been a growing emphasis on cell-based therapies and regenerative medicine, which has driven a heightened call for biopreservation. Advances in biotechnology have enhanced the demand for biopreservation. This would involve long-term storage and transport of sensitive biological materials in research activities on stem cell therapies, gene therapies, and vaccine development. For the cells and tissues to have stability and functionality, these technologies in biopreservation include cryopreservation as well as preservation media. The growth in the market of biopreservation would be able to sustain the pace of innovation in the sector of biotechnology for innovative research and medical applications.

Knowledge on Rare Diseases is Increasing

The increasing awareness of rare and genetic diseases triggers the growth of the biopreservation market. Increasing research activities over rare conditions increase emphasis on preservations of biological samples for diagnostic and therapeutic purposes. By maintaining the viability of these samples for a longer period, biopreservation provides adequate support to the research and development of treatments in such diseases. As rare diseases become increasingly better understood worldwide, there would be increased demand for effective biological material storage and preservation since biopreservation solutions in medical research, clinical diagnostics, and drug development would be required.

Canada Biopreservation Industry

The growth of the Canadian biopreservation market is fueled by an increasing demand for personalized medicine and the trend of advancements in biotechnology. As the country continues to invest in leading-edge research and development, there is thus an emergent imperative to preserve samples of biological matter such as stem cells, tissues, and DNA for both research and medical use. Secondly, the Canadian healthcare sector is keen on improving the diagnosis and treatment of rare diseases, further increasing the need for biopreservation technologies. The country's strong biopharmaceuticals and biotechnology sectors, combined with regulations, would remain positive drivers for the biopreservation market in Canada, going forward. July 2024 Formycon AG, Polpharma Biologics Group BV, Bioeq AG, Teva Canada Ltd. announce that Health Canada has granted Notice of Compliance to Ranopto for the treatment of serious retinal diseases for several conditions in the country.

Biopreservation Market in France

Growth in the French biopreservation market is very strong because of the robust infrastructural health care system, though increasing investments in biotechnology are further adding fuel to this market. The emerging theme of personalized medicine, stem cell therapies, and regenerative medicine require technologies for biopreservation to store and preserve biological samples such as tissues, cells, and DNA. These include research in life sciences by the French government, advances in cryopreservation, and other biopreservation methods that are fueling the growth of the market. With a focus on rare diseases research and innovation in the healthcare sector, France's biopreservation industry will continue to grow at an exponential rate in the coming years.

India Biopreservation Industry

The Indian biopreservation market is growing. It is primarily driven by the increasing demand for personalized medication, higher utilization of biotechnology, and modern health techniques. Gains from India in terms of focus toward regenerative medicine, stem cell research, and gene therapies are likely to drive the development of effective biopreservation methods-the storage and preservation of biological samples such as cells, tissues, and DNA. Meanwhile, increased awareness of rare diseases, government support to strengthen healthcare, and biotechnology sectors is further strengthening market growth. At the same time, with higher investments in life science research and healthcare infrastructure, India's biopreservation industry will quite likely remain on an expansion spree. July 2022- Cellutions BioStorage, a research-to-launch cryopreservation bank was launched in Chennai, India. Cellutions BioStorage is a full-service biomaterial storage and logistics company that partners with biopharmaceutical companies seeking to outsource supply chain management for every stage in a product's lifecycle. The newly constructed facility is of first-class infrastructure and encompasses 25,000 square feet.

Global Biopreservation Company Analysis

The global major players in the biopreservation companies are Thermo Fisher Scientific Inc., Cryport, Inc., Eppendorf AG, BioLife Solutions Inc., Azenta Inc., Merck KGaA, Qiagen NV, and Chart Industries, Inc.

Product- Market breakup in 3 viewpoints:

1. Equipment

2. Media

3. Laboratory Information Management System (LIMS)

Application- Market breakup in 3 viewpoints:

1. Regenerative Medicine

2. Biobanking

3. Drug Discovery

Countries- Market breakup in 25 viewpoints:

1. North America

• 1.1 United States
• 1.2 Canada

2. Europe

• 2.1 France
• 2.2 Germany
• 2.3 Italy
• 2.4 Spain
• 2.5 United Kingdom
• 2.6 Belgium
• 2.7 Netherland
• 2.8 Turkey

3. Asia Pacific

• 3.1 China
• 3.2 Japan
• 3.3 India
• 3.4 Australia
• 3.5 South Korea
• 3.6 Thailand
• 3.7 Malaysia
• 3.8 Indonesia
• 3.9 New Zealand

4. Latin America

• 4.1 Brazil
• 4.2 Mexico
• 4.3 Argentina

5. Middle East & Africa

• 5.1 South Africa
• 5.2 Saudi Arabia
• 5.3 UAE

All the key players have been covered from 4 Viewpoints:

• Business Overview
• Key Persons
• Recent Development & Strategies
• Financial Insights

Key Players Analysis:

1. Thermo Fisher Scientific Inc.

2. Cryport, Inc.

3. Eppendorf AG

4. BioLife Solutions Inc

5. Azenta Inc

6. Merck KGaA

7. Qiagen NV

8. Chart Industries, Inc.